A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia Patients
Clinical trial NCT07039383 · COMPLETED
Trial details
- NCT number
- NCT07039383
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-06-18
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.